|
Neoplasia
Citations 421-430 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia
- Marco Herling, Kaushali A. Patel, Michael A. Teitell, Marina Konopleva, Farhad Ravandi, Ryuji Kobayashi, and Dan Jones
Blood 2008; 111: 328-337.
[Abstract]
[Full text]
[PDF]
FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins
- Xing Du, Satoshi Nagata, Tomoko Ise, Maryalice Stetler-Stevenson, and Ira Pastan
Blood 2008; 111: 338-343.
[Abstract]
[Full text]
[PDF]
A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling
- Katherine Bessette, Mark L. Lang, Roy A. Fava, Martin Grundy, Jennifer Heinen, Laurie Horne, Rosanne Spolski, Amin Al-Shami, Herbert C. Morse, III, Warren J. Leonard, and John A. Kelly
Blood 2008; 111: 344-350.
[Abstract]
[Full text]
[PDF]
Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas
- Santiago Montes-Moreno, Giovanna Roncador, Lorena Maestre, Nerea Martínez, Lydia Sanchez-Verde, Francisca I. Camacho, Jimena Cannata, Jorge L. Martinez-Torrecuadrada, Yulei Shen, Wing C. Chan, and Miguel A. Piris
Blood 2008; 111: 351-358.
[Abstract]
[Full text]
[PDF]
Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell–derived factor-1–induced migration of CD34+ cells from patients with myelodysplasia
- Gwenny M. Fuhler, A. Lyndsay Drayer, Sandra G. M. Olthof, Jan Jacob Schuringa, Paul J. Coffer, and Edo Vellenga
Blood 2008; 111: 359-368.
[Abstract]
[Full text]
[PDF]
Small-molecule XIAP antagonist restores caspase-9–mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells
- Saskia A. G. M. Cillessen, John C. Reed, Kate Welsh, Clemencia Pinilla, Richard Houghten, Erik Hooijberg, José Deurhof, Kitty C. M. Castricum, Pim Kortman, Corine J. Hess, Gert J. Ossenkoppele, Chris J. L. M. Meijer, and Joost J. Oudejans
Blood 2008; 111: 369-375.
[Abstract]
[Full text]
[PDF]
NOTCH1 mutation can be an early, prenatal genetic event in T-ALL
- Minenori Eguchi-Ishimae, Mariko Eguchi, Helena Kempski, and Mel Greaves
Blood 2008; 111: 376-378.
[Abstract]
[Full text]
[PDF]
Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways
- Jerome Tamburini, Nicolas Chapuis, Valérie Bardet, Sophie Park, Pierre Sujobert, Lise Willems, Norbert Ifrah, François Dreyfus, Patrick Mayeux, Catherine Lacombe, and Didier Bouscary
Blood 2008; 111: 379-382.
[Abstract]
[Full text]
[PDF]
Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration
- Javier Redondo-Muñoz, María José Terol, José A. García-Marco, and Angeles García-Pardo
Blood 2008; 111: 383-386.
[Abstract]
[Full text]
[PDF]
t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
- Lisa J. Russell, Takashi Akasaka, Aneela Majid, Kei-ji Sugimoto, E. Loraine Karran, Inga Nagel, Lana Harder, Alexander Claviez, Stefan Gesk, Anthony V. Moorman, Fiona Ross, Helen Mazzullo, Jonathan C. Strefford, Reiner Siebert, Martin J. S. Dyer, and Christine J. Harrison
Blood 2008; 111: 387-391.
[Abstract]
[Full text]
[PDF]
|
|
